Furthermore, although the role of oxidative phosphorylation (OXPHOS) in MMD remains unclear, four genes involved in the OXPHOS pathway, CSK, NARS2, PTPN6, and SMAD2, were found to be differentially expressed between MMD patients and controls [76]. The gene discussed is NARS2; the disease is multiminicore myopathy.